Css - Lab Equipment For Generation/Analysis

combined synopsis/solicitation

Prospective

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01145. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a firm-fixed-price purchase order to the responsible offeror whose proposal represents the best value to the Government. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 334516 ¿ Analytical Laboratory Instrument Manufacturing, and the small business size standard is 1,000 employees. ¿ This requirement is unrestricted. (v) Description of Requirement: The National Heart, Lung, and Blood Institute (NHLBI) requires the following commercially available laboratory equipment to support research on hematopoietic stem cell (HSC)- targeted lipid nanoparticle (LNP) gene delivery for the advancement of in vivo gene therapy. Offerors shall provide equipment meeting or exceeding the salient characteristics below.

SAM.gov

Tender

Manufacturing (Industrial), Government, Residential, Commercial